Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Finding Treatments for COVID-19: A Phase 2 Multi-centre Adaptive Platform Trial to Assess Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)

NCT05041907 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT05041907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05041907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Finding Treatments for COVID-19: A Phase 2 Multi-centre Adaptive Platform Trial to Assess Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)
Lead sponsor
University of Oxford
Phase
Phase 2
Overall status
Recruiting
Start date
September 30, 2021
Completion date
January 31, 2027
Enrollment
3,800 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19